1-225920494-G-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_013328.4(PYCR2):​c.924C>G​(p.Leu308Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000586 in 1,497,182 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00091 ( 1 hom., cov: 31)
Exomes 𝑓: 0.00055 ( 6 hom. )

Consequence

PYCR2
NM_013328.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.373
Variant links:
Genes affected
PYCR2 (HGNC:30262): (pyrroline-5-carboxylate reductase 2) This gene belongs to the pyrroline-5-carboxylate reductase family. The encoded mitochondrial protein catalyzes the conversion of pyrroline-5-carboxylate to proline, which is the last step in proline biosynthesis. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Nov 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 1-225920494-G-C is Benign according to our data. Variant chr1-225920494-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 770123.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.373 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000913 (139/152274) while in subpopulation EAS AF = 0.00907 (47/5184). AF 95% confidence interval is 0.00701. There are 1 homozygotes in GnomAd4. There are 73 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PYCR2NM_013328.4 linkc.924C>G p.Leu308Leu synonymous_variant Exon 7 of 7 ENST00000343818.11 NP_037460.2 Q96C36A0A0S2Z5U6
PYCR2NM_001271681.2 linkc.702C>G p.Leu234Leu synonymous_variant Exon 6 of 6 NP_001258610.1 Q96C36A0A087WTV6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PYCR2ENST00000343818.11 linkc.924C>G p.Leu308Leu synonymous_variant Exon 7 of 7 1 NM_013328.4 ENSP00000342502.6 Q96C36
ENSG00000255835ENST00000432920.2 linkc.575+714C>G intron_variant Intron 5 of 7 2 ENSP00000414068.2 J3KR12
PYCR2ENST00000612039.4 linkc.702C>G p.Leu234Leu synonymous_variant Exon 6 of 6 3 ENSP00000478165.1 A0A087WTV6
PYCR2ENST00000478402.5 linkn.2533C>G non_coding_transcript_exon_variant Exon 5 of 5 2

Frequencies

GnomAD3 genomes
AF:
0.000920
AC:
140
AN:
152156
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00471
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00905
Gnomad SAS
AF:
0.00165
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.00231
AC:
492
AN:
212966
AF XY:
0.00193
show subpopulations
Gnomad AFR exome
AF:
0.000196
Gnomad AMR exome
AF:
0.0115
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00839
Gnomad FIN exome
AF:
0.000102
Gnomad NFE exome
AF:
0.000141
Gnomad OTH exome
AF:
0.00140
GnomAD4 exome
AF:
0.000549
AC:
739
AN:
1344908
Hom.:
6
Cov.:
31
AF XY:
0.000518
AC XY:
347
AN XY:
670230
show subpopulations
African (AFR)
AF:
0.000169
AC:
5
AN:
29572
American (AMR)
AF:
0.0102
AC:
367
AN:
35914
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22678
East Asian (EAS)
AF:
0.00421
AC:
162
AN:
38500
South Asian (SAS)
AF:
0.000894
AC:
70
AN:
78258
European-Finnish (FIN)
AF:
0.0000384
AC:
2
AN:
52016
Middle Eastern (MID)
AF:
0.000374
AC:
2
AN:
5346
European-Non Finnish (NFE)
AF:
0.0000711
AC:
73
AN:
1026572
Other (OTH)
AF:
0.00103
AC:
58
AN:
56052
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
42
84
127
169
211
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000913
AC:
139
AN:
152274
Hom.:
1
Cov.:
31
AF XY:
0.000980
AC XY:
73
AN XY:
74456
show subpopulations
African (AFR)
AF:
0.000168
AC:
7
AN:
41548
American (AMR)
AF:
0.00471
AC:
72
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00907
AC:
47
AN:
5184
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68024
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
9
19
28
38
47
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000538
Hom.:
0
Bravo
AF:
0.00135
Asia WGS
AF:
0.00895
AC:
31
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PYCR2: BP4, BP7 -

not specified Benign:1
Sep 06, 2018
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hypomyelinating leukodystrophy 10 Benign:1
Sep 29, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.66
CADD
Benign
2.7
DANN
Benign
0.67
PhyloP100
0.37
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs181648767; hg19: chr1-226108194; API